A web based tool can be used to calculate and visualize risk associated with drug treatment to facilitate further investigation and application.
This is especially important as microRNA-based tools can be exploited as beneficial therapies for disease treatment and prevention.
Evidence-based tools can be identified by reviewing the medical, public health, and social marketing literature (e.g., systematic reviews, meta-analyses, medical guidelines, and state, federal and international information resources).
Of note, FRET-based tools can be devoted to study direct receptor receptor interactions at the plasma membrane, and it is worth mentioning the use of fluorescent-labeled ligands.
Site-wide heat integration based on total site analysis tools can be used to identify opportunities to further increase energy efficiency.
Based on these references, bioinformatic tools can be used to predict the functional repertoire of a newly sequenced organism.
The rationale for using clinical monitoring tools can be based as well on prevention of disorders that, if allowed to develop, can have relevant effects on outcome.
These tools can be based on a cumulative dose estimation or more simply, likely on the identification of anatomical markers ideally on the CBCTs, and early enough in the course of treatment to propose one or several replanning.
Potential early predictors and suitable non-invasive diagnostic tools can be discovered based on the pathogenetic mechanisms and histological patterns.
These tools can be classified based on three factors: by the data type, by visualization technique type and by the interoperability.
